<DOC>
	<DOCNO>NCT00406887</DOCNO>
	<brief_summary>The purpose phase 3 confirmatory study determine difluprednate ophthalmic emulsion effective treatment treatment uveitis .</brief_summary>
	<brief_title>Study Difluprednate Ophthalmic Emulsion Treatment Uveitis</brief_title>
	<detailed_description>The objective phase 3 study ass efficacy safety 0.05 % difluprednate ophthalmic emulsion ( DFBA ) patient endogenous anterior uveitis , comparison 0.1 % betamethasone sodium phosphate ophthalmic solution ( BP ) .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Panuveitis</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<criteria>Patients diagnose endogenous anterior uveitis panuveitis Patients 10 49 anterior chamber cell within one field anterior chamber observe slit lamp microscopy ( criterion rating sign 2 3 ) Patients age â€°1425 year ( day obtain informed consent ) able accurately express symptom Patients provide write informed consent prior initiation study Patients meet inclusion criterion Patients receive systemic administration corticosteroid immunosuppressive drug within past 1 week prior instillation investigational product Patients receive topical injection corticosteroid eye prior instillation investigational product ( Solution formulation : within past 1 week , depot : within past 2 week ) Patients receive systemic administration nonsteroidal antiinflammatory drug antiphlogistic enzyme within past 3 day prior instillation investigational product Patients receive instillation corticosteroid , nonsteroidal antiinflammatory drug antiphlogistic enzyme within 12 hour prior instillation investigational product Patients glaucoma ocular hypertension Patients corneal abrasion ulcer Patients confirm suspected viral , bacterial fungal keratoconjunctival disease Patients allergy similar drug corticosteroid Patients require use contact lens study period Women might pregnant , lactate woman Patients participate another clinical study within past 3 month initiation present study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>